Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.
David Henka
Advertisement
Articles by David Henka
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves new sunscreen ingredient, first time in 20 years
2
LucyRx and Abarca to merge
3
Hospitals facing financial headwinds can't afford to ignore the mounting threats to 340B
4
FDA sets goal date for ophthalmic version of bevacizumab
5